Asia's Top 10 Based Rabies Vaccines Brand List

June 24, 2024

The demand for oral-based rabies vaccines is on the rise due to ease of administration in wildlife populations. Advances in technology have led to the development of more effective and long-lasting vaccines. The market is expected to grow as more countries prioritize rabies control measures.

HDCV
Rabipur
Changchun Zhuoyi Biological Co., Ltd
Imovax
Verorab
Rabivax

HDCV

Establishment time : HDCV was established in 2005.

website : www.hdcv.com

Main Product : Home décor and furniture.

Company Profile

HDCV is a leading provider of high-quality home décor and furniture, serving customers worldwide with a wide range of stylish and innovative products.

Rabipur

Establishment time : 1989

website : www.rabipur.com

Main Product : Rabies vaccine

Company Profile

Rabipur is a leading pharmaceutical company specializing in the production of rabies vaccines. Established in 1989, the company has grown to have a strong global presence and is known for its high-quality products.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Imovax

Establishment time : Imovax was founded in 1982 and has been a leading provider of rabies vaccines ever since.

website : www.imovax.com

Main Product : Imovax's main product is their rabies vaccine, which is highly effective in preventing the spread of the disease.

Company Profile

Overall, Imovax is dedicated to providing effective vaccines and contributing to the global effort to eradicate rabies.

Verorab

Establishment time : Verorab is a leading rabies vaccine produced by Sanofi Pasteur.

website :

Main Product : Verorab is widely used in both pre-exposure and post-exposure prophylaxis against rabies.

Company Profile

Sanofi Pasteur continues to innovate and improve its products to meet the needs of healthcare professionals and patients worldwide.

Rabivax

Establishment time : Rabivax is a biopharmaceutical company specializing in the production of rabies vaccines.

website :

Main Product : The company's main focus is on providing effective and affordable rabies vaccines to global markets.

Company Profile

With a commitment to public health, Rabivax is dedicated to eliminating rabies through its vaccines.

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326